By a News Reporter-Staff News Editor at Insurance Weekly News The oldest national non-profit organization providing patients with chronic, debilitating and/or life-threatening diseases with one-on-one case management addressing insurance obstacles, medical debt crisis and other barriers to health care released its annual Patient Data Analysis...
Adherex Technologies Inc., today announced that it has received feedback from the FDA at an End-of-Phase 2 meeting held yesterday. During the FDA meeting, Adherex reviewed the opportunity that eniluracil offers to Metastatic Breast Cancer patients who had rapid disease progression on capecitabine. Adherex proposed a small pivotal single arm clinica
By a News Reporter-Staff News Editor at Insurance Weekly News Amerigroup, a wholly owned subsidiary of WellPoint, Inc., announced its Washington health plan has expanded into Tri-Cities, now serving members in Benton and Franklin counties. "Amerigroup brings 17 years of managed care experience to our newest members in the Tri-Cities area," said
AMN Healthcare Services, Inc., healthcare's workforce innovator and largest provider of staffing services, is scheduled to present on Wednesday, June 5, 2013 at 11:00 a.m. Eastern Time at the Jefferies 2013 Healthcare Conference taking place at the Grand Hyatt Hotel in New York, New York. Susan R. Salka, Chief Executive Officer of AMN Healthcare, w
CHI-California Healthcare Institute today submitted a letter to House Appropriators and the California congressional delegation, joined by over 40 biomedical companies, urging them to restore sequestered industry user fees paid to the U.S. Food and Drug Administration in 2013, and to ensure that future across-the-board cuts will not include user fe
For the third consecutive year, a KPMG study commissioned by Canada s Research-Based Pharmaceutical Companies has determined that research and development investments made by Canada s innovative pharmaceutical sector continue to be consistently underreported, by approximately 34 per cent for 2012. The report released today, entitled Summary of 2012
May 24 In 2008, a local doctor flew to Florida for a meeting with ISTA Pharmaceuticals. The case, which dates back to 2007 and was under court-ordered seal in U.S. District Court until Friday, was based on allegations that ISTA improperly marketed one of its drugs, Xibrom, for medical uses not approved by the Food and Drug Administration. The FDA
By a News Reporter-Staff News Editor at Health& Medicine Week SAN DIEGO- Giving patients better access to primary health care could save nearly $4 billion a year in unnecessary emergency room visits for a single common complaint- urinary tract infections- according to a study by the Vattikuti Urology Institute at Henry Ford Hospital in Detroit.
Release date- 23052013- Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay for the diagnosis of diabetes by health care professionals. This is the first HbA1c test that FDA has allowed to be marketed for this use. The HbA1c tests, or A1c tests, currently on the marke
By a News Reporter-Staff News Editor at Health& Medicine Week Masimo announced that its rainbow Acoustic Monitoring? sensor, RAS-125c Acoustic Respiration Cloth Sensor has received U.S. FDA 510 clearance for continuous, noninvasive monitoring of acoustic respiration rate in pediatric patients. Masimo rainbow Acoustic Monitoring noninvasively an
Mumbai: An' import alert' by the US Food and Drug Administration on one of its plants is likely to cause a sales loss of $100 million or over Rs550 crore, Wockhardt said. The FDA has expressed concern on the drugmaker's export-oriented facility in Aurangabad. Analysts familiar with the development had said that the company was issued FDA 483 letter
By a News Reporter-Staff News Editor at Health& Medicine Week Garfield Medical Center has received the Get With The Guidelines - Stroke Gold Plus Quality Achievement Award from the American Heart Association. The award recognizes Garfield Medical Center's commitment and success in implementing a higher standard of care by ensuring that stroke p
Impax Laboratories, Inc. today announced that the Company will present at the Deutsche Bank 38 th Annual Health Care Conference on Thursday, May 30, at 12:00 p.m. Eastern Standard Time. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division.
BUFFALO, N.Y. Drug-maker ISTA Pharmaceuticals has pleaded guilty in a federal case involving its eye drug Xibrom. The Justice Department says the case was settled in U.S. District Court in Buffalo Friday. ISTA, which was acquired by Rochester- based Bausch& Lomb last year, admits to promoting Xibrom for uses beyond what the Food and Drug Administ
May 24 WARRENSBURG Johnson County remained seventh in health outcomes among Missouri counties in the 2013 County Health Rankings, Community Health Services Administrator Debbie Haller said Thursday. Johnson County slipped from fourth place in the first two surveys to seventh place in 2012 and 2013, with mortality rankings dropping from third to
Kinetic Concepts, Inc. has launched a Prevena Peel& Place Dressing with a V.A.C. According to the Company, now more patients will be able to benefit from surgical incision protection in facilities currently utilizing KCI V.A.C. Therapy units and they have provided it, "said Professor Franco Bassetto, Full Professor of Plastic Surgery, University Ho
By a News Reporter-Staff News Editor at Insurance Weekly News Boston, Mass.- A quality improvement platform developed at Boston Children's Hospital could help health care provider groups continuously improve their medical practice, curbing costs and improving patient outcomes. Successful outcomes associated with the platform, called Standardized.
Dean MP Mark Harper met Anna Soubry MP, Minister for Public Health, and David Jones MP, the Secretary of State for Wales, regarding the healthcare policies of the Labour Welsh Assembly Government, and how they are now affecting Foresters. The Aneurin Bevan Health Board, in charge of healthcare for areas of Wales including Monmouthshire, has impleme
Below is a look at some of the headlines for companies that made news in the healthcare sector on May 23, 2013.{ nfg} Omeros Corporation announced its Investigational New Drug Application to evaluate OMS824 in Huntington's disease has been cleared by the U.S. Omeros plans to advance OMS824 into Phase 2 clinical trials for Huntington's disease next
Perosphere Inc. said that it has received U.S. Food and Drug Administration Investigational New Drug clearance to initiate clinical investigations of the safety and efficacy of PER977 to reverse the anticoagulant activity of unfractionated heparin, low molecular weight heparins, fondaparinux, and factor Xa- and IIa-inhibitors. Daiichi Sankyo Compan
BUFFALO, N.Y. Drug-maker ISTA Pharmaceuticals has pleaded guilty in a federal case involving its eye drug Xibrom. The Justice Department says the case was settled in U.S. District Court in Buffalo Friday. ISTA, which was acquired by Rochester- based Bausch& Lomb last year, admits to promoting Xibrom for uses beyond what the Food and Drug Administ
Effective physical therapy management includes a comprehensive marketing strategy, but many physical therapists find it hard to carve out the time to implement a marketing strategy that helps them achieve their goals. According to Nitin Chhoda, a private practice marketing expert and licensed physical therapist, this is one of the biggest mistakes
Dublin- Research and Markets has announced the addition of the "Prefilled Syringes to 2018 Devices, Drugs, Markets, Players and Prospects" report to their offering. The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in r
Premier Health has launched its new Telemedicine Stroke Network using REACH Health telemedicine technology solutions. Premier Health said that telemedicine enables physicians specifically trained in acute stroke care to be electronically transported to the patient's bedside instantly. "We are delighted that Premier Health chose REACH Health as the
Bausch& Lomb Inc. is nearing a deal to be sold to Valeant Pharmaceuticals International Inc. for about $9 billion, The Wall Street Journal reported Friday. Citing people familiar with the situation, the newspaper said Bausch& Lomb based in Rochester, N.Y., and owned by private-equity firm Warburg Pincus LLC could reach a deal with generic drug
